---
schema_version: "secwatch.filing_event.v1"
accession: "0001625297-25-000059"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2025-08-26T23:59:59+00:00"
generated_at: "2026-05-17T09:57:28.976506+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Indivior announces restructuring charges of $39-$50 million as part of Indivior Action Agenda

## Summary
- Headcount reductions expected to incur pre-tax severance charges of approximately $16 to $19 million in Q3 2025.
- Real estate consolidation and exit costs estimated at $15 to $22 million pre-tax, including leasehold improvements and asset write-downs.
- Consulting, legal, and tax planning expenses of about $8 to $9 million pre-tax, recognized in Q3 2025.
- Company is exploring strategic alternatives for OPVEE and its non-U.S. business, which could result in further one-time costs.
- Restructuring charges will be excluded from non-GAAP financial measures, consistent with reporting practices.

## SEC filing metadata
- accession: 0001625297-25-000059
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2025-08-26T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.05
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000059/0001625297-25-000059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000059/indv-20250826.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625297-25-000059
- JSON: https://secwatch.observer/filing/0001625297-25-000059.json
- Plain text: https://secwatch.observer/filing/0001625297-25-000059.txt

## Key facts
- Restructurings & Charges
  Indivior Pharmaceuticals, Inc. announced a restructuring with charges of approximately $39 to $50 million of restructuring charges pre-tax, of which $27-$35 million will be cash affecting enterprise-wide (pre-tax employee severance and related employee exit charges of approximately $16 to $19 million).
  - Type: restructuring
  - Charge: approximately $39 to $50 million of restructuring charges pre-tax, of which $27-$35 million will be cash
  - Affected area: enterprise-wide
  - Headcount: pre-tax employee severance and related employee exit charges of approximately $16 to $19 million
  source text: which will be recognized in the third quarter of 2025. As a result of this initial initiative related to Phase 1, the Company expects to recognize a total of approximately $39 to $50 million of restructuring charges pre-tax, of which $27-$35 million will be cash, and which are expected to be recognized in the third and fourth quarters of 2025. These
  evidence_url: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000059/0001625297-25-000059-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.